WuXi PharmaTech Inc
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From WuXi PharmaTech Inc
Private Company Edition: The flood of venture capital into health care and life science firms continues with Perceptive closing a $1.1bn credit fund and Sanofi investing $50m in Jeito Capital. Also, Ambrx closed a $200m crossover round as biopharma remains on track for a record funding year.
As China tightens its grip over clinical research using human genetic data in the country, and the US increases scrutiny over the use of personal data, multinational drug developers may face a difficult choice or even create separate entities to cater to local regulatory requirements. WuXi NextCODE provides one interesting case study.
Private Company Edition: Arvelle, insitro, AbCellera and the University of Michigan have something in common – they each attracted more than $100m in venture capital investment.
In addition to our daily in-depth coverage of key events relating to the coronavirus pandemic, we’re bringing you a periodic round-up of other significant developments.
- Contract Research, Toxicology Testing-CRO
- Laboratory Testing Services
- Medical Devices
Drug Discovery Tools
- Drug Discovery Tools
- Other Names / Subsidiaries
- Crelux GmbH
- Faxian Therapeutics
- JW Biotechnology (Shanghai) Co., Ltd
- ResearchPoint Global
- STA Pharmaceutical Co., Ltd.
- WuXi AppTec
- WuXi Merger Limited
- XenoBiotic Laboratories, Inc.